<DOC>
	<DOCNO>NCT01715246</DOCNO>
	<brief_summary>The primary objective clinical study show infant feed standard starter infant formula 2 Human Milk Oligosaccharides ( HMOs ) growth line infant feed standard starter infant formula without HMOs .</brief_summary>
	<brief_title>Clinical Safety New Infant Starter Formula Containing 2 Human Milk Oligosaccharides ( HMOs )</brief_title>
	<detailed_description />
	<criteria>Healthy baby Full term baby ( 37 week ≤ gestation ≤ 42 week ) birth weight 2500 g 4500g Having obtain baby 's legal representative 's informed consent . FF group : baby age birth 14 day , exclusively formulafed time enrollment , whose mother independently elect , enrollment , breastfeed • BF group : baby age 3 month ( +/ 5 day ) , exclusively breastfed since birth . Congenital illness malformation may affect growth Significant prenatal and/or serious postnatal disease enrollment ( medical decision ) Minor parent ( ) Newborn whose parent / caregiver expect comply study procedure Currently participate participate another clinical trial since birth , except BF group , vaccine study allow .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>healthy babbies</keyword>
	<keyword>infant formula</keyword>
	<keyword>growth</keyword>
	<keyword>HMO</keyword>
</DOC>